Clinical Trial Update: A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluated the magnitude and duration of response of MK0954 versus placebo in hypertension, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MK0954

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-07-14